Experimental drug ameliorates symptoms of neurodegenerative brain disease in mice

In cooperation with colleagues in Munich and Göttingen, researchers at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have analyzed a novel substance that could serve as a prototype for the development of drugs to treat Alzheimers and other brain diseases. Known as anle138b, this substance ameliorated disease symptoms in mice and improved their cognition. The scientists report on these findings in the journal Acta Neuropathologica. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)